We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Laser-Based Tool Injects Nanoparticles and Macromolecules into Cells with Minimal Damage

By LabMedica International staff writers
Posted on 29 Apr 2015
Print article
Image: BLAST drives nanoparticles, enzymes, antibodies, and bacteria into cells at the rate of 100,000 cells per minute—significantly faster than current technology (Photo courtesy of UCLA - University of California, Los Angeles).
Image: BLAST drives nanoparticles, enzymes, antibodies, and bacteria into cells at the rate of 100,000 cells per minute—significantly faster than current technology (Photo courtesy of UCLA - University of California, Los Angeles).
Cell biologists have developed a laser-based tool that is capable of injecting large objects such as nanoparticles, bacteria, or macromolecules into cells at a speed much greater than allowed by current technologies.

Investigators at the University of California, Los Angeles (USA) call the new tool "biophotonic laser-assisted surgery tool (BLAST)." BLAST is, in essence, a silicon chip with an array of micrometer-wide holes, each surrounded by an asymmetric, semicircular coating of titanium.

A reservoir of liquid that includes the particles to be delivered is located beneath the holes. Target cells are loaded onto the silicon chip, and a laser pulse is used to heat the titanium coating, which instantly boils the water layer adjacent to parts of the cell. This generates an array of microcavitation bubbles that form pores in adjacent cell membranes through which cargo is gently driven by pressurized flow.

The investigators reported in the April 6, 2015, online edition of the journal Nature Methods that the platform delivered large items including bacteria, enzymes, antibodies, and nanoparticles into diverse cell types with high efficiency—up to 100,000 cells per minute—and cell viability.

“The new information learned from these types of studies could assist in identifying pathogen targets for drug development, or provide fundamental insight on how the pathogen–host interaction enables a productive infection or effective cellular response to occur,” said contributing author Dr. Michael Teitell, professor of pediatric and developmental pathology at the University of California, Los Angeles.

Related Links:

University of California, Los Angeles


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.